Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dowdy

Showing results (61-70 of 104) with videos related to

Pageof 11
Sort By:
Clinical Pharmacology and Therapeutics|January 25, 2003
Effects of nelfinavir and its M8 metabolite on lymphocyte P-glycoprotein activity during antiretroviral therapyJohn P Donahue, David Dowdy, Krishna K Ratnam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 17, 2025
Projecting the impact and costs of near point-of-care tuberculosis screening assays in community-based active case findingJason R Andrews, Emily A Kendall, Adithya Cattamanchi, et al.
Eclinicalmedicine|November 2, 2020
The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysisLucia Cilloni, Han Fu, Juan F Vesga, et al.
Infectious Diseases of Poverty|June 24, 2020
Spatial distribution of people diagnosed with tuberculosis through routine and active case finding: a community-based study in Kampala, UgandaKatherine O Robsky, Peter J Kitonsa, James Mukiibi, et al.
Lancet (London, England)|July 24, 2012
A call to action for comprehensive HIV services for men who have sex with menChris Beyrer, Patrick S Sullivan, Jorge Sanchez, et al.
Emerging Infectious Diseases|March 2, 2025
Model-Based Analysis of Impact, Costs, and Cost-effectiveness of Tuberculosis Outbreak Investigations, United StatesSourya Shrestha, Lucia Cilloni, Garrett R Beeler Asay, et al.
AIDS and Behavior|January 26, 2017
Challenges in the Evaluation of Interventions to Improve Engagement Along the HIV Care Continuum in the United States: A Systematic ReviewKathryn A Risher, Sunaina Kapoor, Alice Moji Daramola, et al.
Public Health Reports (Washington, D.C. : 1974)|June 14, 2026
Variation by Race and Ethnicity in the Population Attributable Fractions Associated With Key Tuberculosis Risk Factors in the United StatesMeha Mohammud Ahmed, Raeesa Manjoo-Docrat, Katherine O Robsky, et al.
Global Heart|November 5, 2020
The Relationship of COVID-19 Severity with Cardiovascular Disease and Its Traditional Risk Factors: A Systematic Review and Meta-AnalysisKunihiro Matsushita, Ning Ding, Minghao Kou, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 7, 2016
Timing of Antiretroviral Treatment, Immunovirologic Status, and TB Risk: Implications for Testing and TreatmentApril C Pettit, Adell Mendes, Cathy Jenkins, et al.
Pageof 11

Showing results (61-70 of 104) with videos related to

Sort By:
Pageof 11
Clinical Pharmacology and Therapeutics|January 25, 2003
Effects of nelfinavir and its M8 metabolite on lymphocyte P-glycoprotein activity during antiretroviral therapyJohn P Donahue, David Dowdy, Krishna K Ratnam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 17, 2025
Projecting the impact and costs of near point-of-care tuberculosis screening assays in community-based active case findingJason R Andrews, Emily A Kendall, Adithya Cattamanchi, et al.
Eclinicalmedicine|November 2, 2020
The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysisLucia Cilloni, Han Fu, Juan F Vesga, et al.
Infectious Diseases of Poverty|June 24, 2020
Spatial distribution of people diagnosed with tuberculosis through routine and active case finding: a community-based study in Kampala, UgandaKatherine O Robsky, Peter J Kitonsa, James Mukiibi, et al.
Lancet (London, England)|July 24, 2012
A call to action for comprehensive HIV services for men who have sex with menChris Beyrer, Patrick S Sullivan, Jorge Sanchez, et al.
Emerging Infectious Diseases|March 2, 2025
Model-Based Analysis of Impact, Costs, and Cost-effectiveness of Tuberculosis Outbreak Investigations, United StatesSourya Shrestha, Lucia Cilloni, Garrett R Beeler Asay, et al.
AIDS and Behavior|January 26, 2017
Challenges in the Evaluation of Interventions to Improve Engagement Along the HIV Care Continuum in the United States: A Systematic ReviewKathryn A Risher, Sunaina Kapoor, Alice Moji Daramola, et al.
Public Health Reports (Washington, D.C. : 1974)|June 14, 2026
Variation by Race and Ethnicity in the Population Attributable Fractions Associated With Key Tuberculosis Risk Factors in the United StatesMeha Mohammud Ahmed, Raeesa Manjoo-Docrat, Katherine O Robsky, et al.
Global Heart|November 5, 2020
The Relationship of COVID-19 Severity with Cardiovascular Disease and Its Traditional Risk Factors: A Systematic Review and Meta-AnalysisKunihiro Matsushita, Ning Ding, Minghao Kou, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 7, 2016
Timing of Antiretroviral Treatment, Immunovirologic Status, and TB Risk: Implications for Testing and TreatmentApril C Pettit, Adell Mendes, Cathy Jenkins, et al.
Pageof 11